Table 2 Survival and clinicopathologic features in fibrolamellar carcinoma and hepatocellular carcinoma (HCC) with and without cirrhosis
Fibrolamellar carcinoma (n=20) | HCC without cirrhosis (n=32) | HCC with cirrhosis (n=30) | P-valuea | |
|---|---|---|---|---|
Age (years) b | ||||
<40 | 16 (84) | 3 (9) | 4 (13) | <0.001 |
≥40 | 3 (16) | 29 (91) | 26 (87) | |
Gender b | ||||
Female | 9 (47) | 14 (44) | 25 (83) | 0.2 |
Male | 10 (53) | 18 (56) | 5 (17) | |
Tumor size (cm) b | ||||
<10 | 5 (31) | 19 (59) | 26 (87) | 0.003 |
≥10 | 11 (69) | 13 (41) | 4 (13) | |
‘Pale bodies’ | 8 (40) | 0 | 0 | <0.001 |
5-year survival— nonmetastatic cases | 62% | 58% | 27% | 0.03 |
